Results 221 to 230 of about 6,918,921 (334)
Taking advantage of the media to expand the influence of IUCN’s Green List of Protected Areas in China [PDF]
Baodang Liu
openalex +1 more source
Citrus Greening Disease and the Greening Bacterium [PDF]
Garnier, M., Bové, Joseph M.
openaire +4 more sources
A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp+13 more
wiley +1 more source
Machine learning analysis of drug solubility via green approach to enhance drug solubility for poor soluble medications in continuous manufacturing. [PDF]
Lahiq AA, Alshehri AA, Alsharif ST.
europepmc +1 more source
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald+18 more
wiley +1 more source
<i>Solanum baumii</i> (Solanaceae), a New Species From Northeastern Thailand. [PDF]
Chatan W, Munglue P, Promprom W.
europepmc +1 more source
Crystal Structure and Theoretical Analysis of Green Gold Au30(S-tBu)18 Nanomolecules and Their Relation to Au30S(S-tBu)18 [PDF]
Amala Dass+10 more
openalex +1 more source
Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma
The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias+12 more
wiley +1 more source